San Marino Tech News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on San Marino Tech News.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 23, 2026

35 minutes ago

Apogee Therapeutics Announces Positive Phase 2 Part A 52-Week Data of Zumilokibart (APG777), Demonstrating Maintenance and Deepening of Responses with Every 3- and 6-Month Dosing in Moderate-to-Severe Atopic Dermatitis

GlobeNewswire

an hour ago

General (Ret.) Christopher Cavoli, Former EUCOM Commander and Supreme Allied Commander Europe, Joins Pallas Speakers Bureau

GlobeNewswire

2 hours ago

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

GlobeNewswire

2 hours ago

Proofpoint Redefines Email and Data Security for the Agentic Workspace

GlobeNewswire

3 hours ago

Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs

GlobeNewswire

3 hours ago

BOSS Zhipin Continues Share Repurchase Program, Reinforcing Commitment to Shareholder Returns

GlobeNewswire

3 hours ago

Rakovina Therapeutics to Present New Data at the AACR Annual Meeting 2026 – World’s Premier Cancer Research Forum

GlobeNewswire

4 hours ago

Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs

GlobeNewswire

4 hours ago

Groundbreaking Danish research project launches to cure Parkinson’s disease

GlobeNewswire

4 hours ago

Persica Pharmaceuticals Appoints Dr Edward Littler as Executive Chairman and David Watson as Chief Executive Officer

GlobeNewswire

5 hours ago

Basilea startet erste klinische Studie am Menschen für neuartiges Antibiotikum BAL2420

GlobeNewswire

5 hours ago

Basilea announces start of first‑in‑human study of novel antibiotic BAL2420

GlobeNewswire

7 hours ago

NetAlly Launches New LinkRunner Network and Cable Tester

GlobeNewswire

8 hours ago

Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula

GlobeNewswire

$HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China$

11 hours ago

HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China

GlobeNewswire